Trial Profile
An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2019
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- Acronyms FUSE
- Sponsors Pfizer
- 22 Jul 2019 Results published in the Diabetes Care.
- 26 Jun 2012 Actual patient number changed from 2725 to 7439 as reported by ClinicalTrials.gov.
- 27 Mar 2012 Actual end date (January 2012) added as reported by ClinicalTrials.gov.